21 – 30 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Bladder activation: afferent mechanisms.
(
- Contribution to journal › Article
-
Mark
Treatment of the overactive bladder: possible central nervous system drug targets.
(
- Contribution to journal › Article
-
Mark
Pharmacologic perspective on the physiology of the lower urinary tract.
(
- Contribution to journal › Article
-
Mark
Feedback microwave thermotherapy versus TURP for clinical BPH - A randomized controlled multicenter study
(
- Contribution to journal › Article
- 2000
-
Mark
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
(
- Contribution to journal › Article
- 1999
-
Mark
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
(
- Contribution to journal › Article
- 1998
-
Mark
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum
(
- Contribution to journal › Article
- 1996
-
Mark
Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis
(
- Contribution to journal › Article
-
Mark
Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
(
- Contribution to journal › Article
- 1995
-
Mark
Long-term metabolic effects of urinary diversion on skeletal bone: histomorphometric and mineralogic analysis
(
- Contribution to journal › Article